1306
BELYKH et al.
[1H, 3-(CH=CHHcis), J 12.0 Hz], 5.16 s (1H,
132-OH), 4.26 4.32 m (2H, H17, H18), 3.78 s (1H,
132-CO2CH3), 3.64 s [3H, 17-(CH2CH2COOCH3)],
3.48 s (3H, 12-CH3), 3.14 s (3H, 2-CH3), 3.00 s (3H,
7-CH3), 3.42 3.58 m [2H, 8-(CH2CH3)], 2.19 2.46 m
[4H, 17-(CH2CH2COOCH3)], 1.53 t (3H, 8-CH2CH3,
J 8.0 Hz), 1.42 d (3H, 18-CH3, J 8.0 Hz).
[4H, 17-(CH2CH2COOCH3)], 1.53 1.70 m (3H,
8-CH2CH3), 1.48 d (3H 18-CH3, J 8.0 Hz); minor
isomer: 9.09 s (1H, H10), 9.02 s (1H, H5), 8.02 s (1H,
H20), 7.78 d.d [1H, 3-(CH=CH2), J 18.8 and 8.0 Hz],
6.03 m [1H, 3-(CH=CHHtrans)], 5.90 br.d [1H,
3-(CH=CHHcis) J 12.0 Hz], 4.15 4.08 m [2H,
15-(CH2CO2CH3)], 4.09 m (1H, H18), 3.89 3.92 m
(1H, H17), 3.69 s [3H, 15-(CH2COOCH3)], 3.65 s
[3H, 17-(CH2CH2COOCH3)], 3.37 s (3H, 12-CH3),
3.13, 3.11 both br.s [both 6H, 2-CH3, 12-CH3, 7-CH3,
13-C(O)N(CH3)(CH3)], 2.96 s [3H, 13-C(O)N(CH3)
(CH3)], 3.47 3.60 m [2H, 8-(CH2CH3)], 2.03 2.50 m
[2H, 17-(CH2CH2COOCH3)], 1.53 1.70 m (3H,
8-CH2CH3), 1.44 d (3H, 18-CH3, J 8.0 Hz).
b. From 19 mg of compound II and 9 mg of nickel
acetylacetonate, 14 mg (65%) of complex VII was
obtained. The complexes obtained by procedures a
and b coincide in chromatographic mobility (TLC)
and spectral characteristics.
Ni-methylpyropheophorbid a (VIII). a. From
34 mg of compound III and 12 mg of nickel acetate,
17 mg (45%) of complex VIII identical to the sample
prepared by procedure b was obtained.
Ni-(13-N-methylamide)-15,17-dimethyl ester of
chlorin e6 (Ni V). a. From 28 mg of compound V
and 8 mg of nickel acetate, 6 mg (21%) of complex
X identical to the sample prepared by procedure b was
obtained.
b. From 29 mg of compound III and 15 mg of
nickel acetylacetonate, 25 mg (78%) of complex VIII
was obtained. Electronic absorption spectrum (CHCl3),
1
, nm: 652, 607, 543, 501, 422, 397. H NMR spec-
trum (CDCl3, 400 MHz), , ppm: 9.30 s (1H, H10),
9.06 s (1H, H5), 8.16 s (1H, H20), 7.77 d.d [1H,
3-(CH=CH2), J 16.0 and 8.0 Hz], 6.03 d.d [1H,
3-(CH=CHHtrans), J 16.0 and 2.0 Hz], 5.97 d.d [1H,
3-(CH=CHHcis) J 12.0 and 2.0 Hz], 4.87 d (1H,
b. From 29 mg of compound V and 13 mg of
nickel acetylacetonate, 22 mg (70%) of complex X
was obtained. Electronic absorption spectrum (CHCl3),
1
, nm: 634, 497, 409. H NMR (CDCl3, 400 MHz),
, ppm: 9.09 s (1H, H10), 9.03 s (1H, H5), 8.03 s (1H,
H13(2),A, J 22.0 Hz), 4.79 d (1H, H13(2),B, J 21.0 Hz),
3.97 4.01 m 18, (1H, H17), 4.28 q (1H, J 8.0 Hz),
3.60 s [3H, 17-(CH2CH2COOCH3)], 3.48 s (3H,
12-CH3), 3.15 s (3H, 2-CH3), 3.12 s (3H, 7-CH3),
3.58 3.61 m [2H, 8-(CH2CH3)], 2.06 2.48 m [4H,
17-(CH2CH2COOCH3)], 1.53 1.62 m (6H, 18-CH3,
8-CH2CH3).
H20), 7.79 d.d [1H, 3-(CH=CH2), J 17.0 and 12.0 Hz],
6.02 d.d [1H, 3-(CH=CHHtrans), J 17.0 and 2.0 Hz],
5.93 d.d [1H, 3-(CH=CHHcis), J 12.0 and 2.0 Hz],
6.22 br.q (1H, 13-CONHCH3, J 4.8 Hz), 4.91 d (1H,
H
15(1),A, J 20.0 Hz), 4.50 d (1H, H15(1),B, J 20.0 Hz),
4.11 q (1H, H18, J 7.2 Hz), 3.94 3.97 m (1H, H17),
3.82 [3H, 15-(CH2COOCH3)], 3.64 [1H,
s
s
Ni-(13-N,N-dimethylamide)-15,17-dimethyl ester
of chlorin e6 (IX). a. From 34 mg of compound IV
and 10 mg of nickel acetate, 9 mg (25%) of complex
IX identical to the sample prepared by procedure b
was obtained.
17-(CH2CH2COOCH3)], 3.20 s (3H, 12-CH3), 3.18 d
(3H, 13-CONHCH3, J 5.2 Hz), 3.12 s (3H, 2-CH3),
3.11 s (3H, 7-CH3), 3.25 3.50 m [2H, 8-(CH2CH3)],
2.27 2.50 m [4H, 17-(CH2CH2COOCH3)], 1.54
1.58 m (3H, 8-CH2CH3), 1.46 d (3H, 18-CH3, J
7.2 Hz).
b. From 20 mg of compound IV and 9 mg of
nickel acetylacetonate, 15 mg (69%) of complex IX
was obtained. Electronic absorption spectrum (CHCl3),
Mixture of diastereoisomeric Ni-methylpheo-
phorbid a (VI) and Ni-methylpheophorbid a (XII).
From 78 mg of compound I and 33 mg of nickel
acetylacetonate, 9 mg (10%) of a mixture of stereo-
isomeric complexes VI and XII was obtained. Elec-
tronic absorption spectrum (CHCl3), , nm: 652, 539,
496, 416. 1H NMR (CDCl3, 400 MHz), , ppm:
complex VI: 9.31 s (1H, H10), 9.07 s (1H, H5), 8.17 s
(1H, H20), 7.75 d.d [1H, 3-(CH=CH2), J 17.5 and
12.0 Hz], 6.02 d.d [1H, 3-(CH=CHHtrans), J 17.6 and
1.6 Hz], 5.98 d.d [1H, 3-(CH=CHHcis), J 12.0 and
2.0 Hz], 5.79 s (1H, H13(2)), 4.20 4.28 m (2H, H17,
H18), 3.91 s (3H, 132-CO2CH3), 3.58 s [3H,
1
, nm: 642, 495, 402. H NMR (CDCl3, 400 MHz),
, ppm: major isomer, 9.11 s (1H, H10), 9.04 s (1H,
H5), 8.06 s (1H, H20), 7.80 d.d [1H, 3-(CH=CH2),
J 18.8 and 8.0 Hz], 6.03 m [1H, 3-(CH=CHHtrans)],
5.90 br.d [1H, 3-(CH=CHHcis) J 12.0 Hz], 5.26 d (1H,
H15(1),A , J 19.0 Hz), 4.48 d (1H, H15(1),B, J 19.0 Hz),
4.06 4.09 m (1H, H18), 3.89 3.92 m (1H, H17),
3.90
s
[3H, 15-(CH2COOCH3)], 3.63 s [3H,
17-(CH2CH2COOCH3)], 3.34 s (3H, 12-CH3), 3.13,
3.11 both br.s [both 6H, 2-CH3, 12-CH3, 7-CH3,
13-C(O)N(CH3)(CH3)], 2.94 s [3H, 13-C(O)N(CH3)
(CH3)], 3.47 3.60 m [2H, 8-(CH2CH3)], 2.03 2.50 m
RUSSIAN JOURNAL OF GENERAL CHEMISTRY Vol. 77 No. 7 2007